ES2969042T3 - Ensayo de colágeno tipo XVIII - Google Patents
Ensayo de colágeno tipo XVIII Download PDFInfo
- Publication number
- ES2969042T3 ES2969042T3 ES18713147T ES18713147T ES2969042T3 ES 2969042 T3 ES2969042 T3 ES 2969042T3 ES 18713147 T ES18713147 T ES 18713147T ES 18713147 T ES18713147 T ES 18713147T ES 2969042 T3 ES2969042 T3 ES 2969042T3
- Authority
- ES
- Spain
- Prior art keywords
- antibody
- type xviii
- time point
- collagen
- xviii collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1704182.3A GB201704182D0 (en) | 2017-03-16 | 2017-03-16 | Collagen tye XVIII assay |
| PCT/EP2018/056320 WO2018167111A1 (en) | 2017-03-16 | 2018-03-14 | Collagen type xviii assay |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2969042T3 true ES2969042T3 (es) | 2024-05-16 |
Family
ID=58688412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18713147T Active ES2969042T3 (es) | 2017-03-16 | 2018-03-14 | Ensayo de colágeno tipo XVIII |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20200087385A1 (https=) |
| EP (1) | EP3596120B1 (https=) |
| JP (1) | JP7275040B2 (https=) |
| ES (1) | ES2969042T3 (https=) |
| GB (1) | GB201704182D0 (https=) |
| WO (1) | WO2018167111A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201901710D0 (en) * | 2019-02-07 | 2019-03-27 | Nordic Bioscience As | Collagen type 23 assay |
| GB202019578D0 (en) * | 2020-12-11 | 2021-01-27 | Nordic Bioscience As | Assay for detecting Collagen XVIII biomarkers |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2007049749A1 (ja) * | 2005-10-28 | 2009-04-30 | ディナベック株式会社 | 血液凝固異常の治療方法 |
-
2017
- 2017-03-16 GB GBGB1704182.3A patent/GB201704182D0/en not_active Ceased
-
2018
- 2018-03-14 EP EP18713147.9A patent/EP3596120B1/en active Active
- 2018-03-14 JP JP2019550764A patent/JP7275040B2/ja active Active
- 2018-03-14 ES ES18713147T patent/ES2969042T3/es active Active
- 2018-03-14 WO PCT/EP2018/056320 patent/WO2018167111A1/en not_active Ceased
- 2018-03-14 US US16/494,441 patent/US20200087385A1/en not_active Abandoned
-
2022
- 2022-12-22 US US18/145,767 patent/US20230340092A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3596120B1 (en) | 2023-12-13 |
| WO2018167111A1 (en) | 2018-09-20 |
| US20200087385A1 (en) | 2020-03-19 |
| EP3596120C0 (en) | 2023-12-13 |
| JP2020514368A (ja) | 2020-05-21 |
| EP3596120A1 (en) | 2020-01-22 |
| JP7275040B2 (ja) | 2023-05-17 |
| US20230340092A1 (en) | 2023-10-26 |
| GB201704182D0 (en) | 2017-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2837858T3 (es) | Ensayos para determinar biomarcadores del sistema calicreína plasmática | |
| JP6162115B2 (ja) | 病理学バイオマーカーアッセイ | |
| CN110208533B (zh) | Pkal-介导的病症的评估、测定和治疗 | |
| US9835631B2 (en) | Combined biomarker measurement of fibrosis | |
| US20160061844A1 (en) | PIIINP Neo-epitope Assay | |
| CN114270190A (zh) | 用于评估心力衰竭的测定 | |
| US20230340092A1 (en) | Collagen Type XVIII Assay | |
| US20160151405A1 (en) | Pappalysin Regulator | |
| Kjeld et al. | The endothelial specific isoform of type XVIII collagen correlates to annual bleeding rate in haemophilia patients | |
| JP7699608B2 (ja) | 線維症のバイオマーカー | |
| Manon-Jensen et al. | Initiation of the wound healing cascade in inflammatory bowel disease: assessment of Von Willebrand factor ADAMTS-13 processing and formation in crohn’s disease | |
| US20230280350A1 (en) | Collagen Type XVI Assay | |
| AU2018351632B2 (en) | Collagen type XVI assay | |
| US12560610B2 (en) | Sparc assay | |
| US20260029403A1 (en) | Type XIX Collagen Assay | |
| JP7169356B2 (ja) | Sparcアッセイ | |
| US20200340994A1 (en) | Tumstatin Assay | |
| WO2018050671A1 (en) | Nidogen-1 fragments assay | |
| NZ741448A (en) | Immunoassay for the detection of cleaved high molecular weight kininogen | |
| NZ741448B2 (en) | Immunoassay for the detection of cleaved high molecular weight kininogen | |
| BR122023015873B1 (pt) | Método in vitro para avaliar um tratamento de um distúrbio mediado por calicreína plasmática (pkal) em um sujeito |